Drug Trial Radar · NCT06709196
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
Last checked: Nov 20, 2026Latest source record: Jan 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
248
Planned (sponsor's estimate)
Start
Jan 7, 2025
Primary completion
Jan 2027
Study completion Jan 2027
Sponsor
- Lead sponsor
- Copenhagen University Hospital, RigshospitaletAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial is to test whether postoperative antibiotics targeted towards bacteria in the urine can reduce the risk of infection after surgical removal of the bladder (cystectomy) compared to a standardised antibiotic prophylaxis. Participants undergoing cystectomy will be randomly assigned to postoperatively receive (A) a standardised orally administered antibiotic prophylaxis currently given at Rigshospitalet, Copenhagen or (B) a conventional orally administered antibiotic prophylaxis targeting bacteria found in the urine postoperatively. The investigators' hypothesis is that the targeted prophylactic antibiotic strategy will reduce the number of infection-related readmissions within 90 days of surgery compared to the standardised prophylaxis.
Conditions
- Cystectomy
- Bladder Cancer Requiring Cystectomy
- Postoperative Infections
- Antibiotic Prophylaxis
- Ileal Conduit
Interventions
PivmecillinamDrug
Orally administered pivmecillinam 400mg
PivmecillinamDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Amoxicillin clavulanic acidDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
AmoxicillinDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
CefuroximeDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
CiprofloxacinDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
LinezolidDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
NitrofurantoinDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
TrimethoprimDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Sulfamethoxazole trimethoprimDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
FluconazoleDrug
Orally administered targeted antimicrobial prophylaxis based on a urine culture.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Infection-related readmission rateTime frame: 90 days after surgery
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Department of Urology, Aalborg University Hospital
Aalborg, Denmark · Not yet recruiting
Department of Urology, Aarhus University Hospital
Aarhus, Denmark · Not yet recruiting
Department of Urology, Rigshospitalet
Copenhagen, Denmark · Recruiting
Department of Urology, Herlev and Gentofte Hospital
Herlev, Denmark · Not yet recruiting
Department of Urology, Odense University Hospital
Odense, Denmark · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.